Used as a potent and selective antagonist for the CB1 cannabinoid receptor, this compound is primarily applied in pharmacological research to study the endocannabinoid system. It helps in investigating appetite regulation, metabolic disorders, and substance dependence. Due to its high affinity and stereochemical specificity, it serves as a valuable tool compound in developing therapies targeting obesity, diabetes, and addiction. Its structure supports strong receptor binding, making it useful in structure-activity relationship (SAR) studies for designing new CB1 modulators.